Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278668
Status:
UNKNOWN
Last Update Posted:
2008-05-21
First Post:
2006-01-16
Brief Title:
ECT Schizophrenia Serotonin Study
Sponsor:
Shaar Menashe Mental Health Center
Organization:
Shaar Menashe Mental Health Center
Study Overview
Official Title:
Serotonin Uptake to Lymphocytes and Citalopram Platelets Binding of Treatment-Resistant Schizophrenia Patients Before and After Electroconvulsive Therapy
Status:
UNKNOWN
Status Verified Date:
2008-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
Detailed Description:
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None